These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24055243)

  • 1. Editorial comment.
    Vemana G; Andriole GL
    Urology; 2013 Nov; 82(5):1081-2. PubMed ID: 24055243
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and american urological association symptom score.
    Babayan RK
    J Urol; 2014 May; 191(5):1289. PubMed ID: 24745490
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment.
    Montie JE
    Urology; 2009 May; 73(5):939; author reply 939. PubMed ID: 19394485
    [No Abstract]   [Full Text] [Related]  

  • 4. The evolution of the PCPT from clinical to molecular analyses.
    Hoque A
    Nat Clin Pract Oncol; 2006 Nov; 3(11):581. PubMed ID: 17080169
    [No Abstract]   [Full Text] [Related]  

  • 5. Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.
    Ammar H; Malani AK; Gupta C
    BMJ; 2006 Sep; 333(7569):654; author reply 654. PubMed ID: 16990336
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of prostate cancer with finasteride.
    Schwartz DT
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562808
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of prostate cancer with finasteride.
    Burke HB
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562806
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of finasteride on risk of prostate cancer: how little we really know.
    Rubin MA; Kantoff PW
    J Cell Biochem; 2004 Feb; 91(3):478-82. PubMed ID: 14755678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of prostate cancer with finasteride.
    Ross RK; Skinner E; Cote RJ
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562807
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of prostate cancer with finasteride.
    Barzell WE
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562803
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer.
    Orvieto M; Eggener S
    Eur Urol; 2009 May; 55(5):1073-4. PubMed ID: 19200640
    [No Abstract]   [Full Text] [Related]  

  • 12. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
    Thompson IM; Lucia MS; Redman MW; Darke A; La Rosa FG; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer prevention with 5 alpha-reductase inhibitors.
    Parekh DJ
    Recent Results Cancer Res; 2011; 188():109-14. PubMed ID: 21253793
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer.
    Adolfsson J
    Eur Urol; 2009 May; 55(5):1074. PubMed ID: 19200637
    [No Abstract]   [Full Text] [Related]  

  • 15. 'Clandestine' prostate cancer haunts.
    Chapman B
    CAP Today; 1996 Feb; 10(2):1, 34-6, 38 passim. PubMed ID: 10160261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Practical follow-up of a patient treated with finasteride in screening for prostate cancer].
    Villers A
    Prog Urol; 2008 Apr; 18 Suppl 3():S58-62. PubMed ID: 18455086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.
    Reed AB; Parekh DJ
    Curr Opin Urol; 2009 May; 19(3):238-42. PubMed ID: 19318950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PCPT trial: expected bias and their management].
    Irani J
    Prog Urol; 2008 Apr; 18 Suppl 3():S44-6. PubMed ID: 18455083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline supports long-term use of medication to lower prostate cancer risk.
    Mitka M
    JAMA; 2009 May; 301(17):1753-4. PubMed ID: 19417182
    [No Abstract]   [Full Text] [Related]  

  • 20. New answers from the Prostate Cancer Prevention Trial on the chemoprevention of prostate cancer.
    Ankerst DP; Thompson IM
    Arch Ital Urol Androl; 2006 Dec; 78(4):154-6. PubMed ID: 17269622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.